{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:49:20Z","timestamp":1791992960787,"version":"4.4.0"},"reference-count":100,"publisher":"Oxford University Press (OUP)","issue":"61","license":[{"start":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T00:00:00Z","timestamp":1683158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R25CA203650"],"award-info":[{"award-number":["R25CA203650"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Energy balance accounts for an individual\u2019s energy intake, expenditure, and storage. Each aspect of energy balance has implications for the pharmacokinetics of cancer treatments and may impact an individual\u2019s drug exposure and subsequently its tolerance and efficacy. However, the integrated effects of diet, physical activity, and body composition on drug absorption, metabolism, distribution, and excretion are not yet fully understood. This review examines the existing literature on energy balance, specifically the role of dietary intake and nutritional status, physical activity and energy expenditure, and body composition on the pharmacokinetics of cancer therapeutics. As energy balance and pharmacokinetic factors can be influenced by age-related states of metabolism and comorbidities, this review also explores the age-related impact of body composition and physiologic changes on pharmacokinetics among pediatric and older adult populations with cancer.<\/jats:p>","DOI":"10.1093\/jncimonographs\/lgad010","type":"journal-article","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T10:57:24Z","timestamp":1683197844000},"page":"3-11","source":"Crossref","is-referenced-by-count":23,"title":["Pharmacokinetics of cancer therapeutics and energy balance: the role of diet intake, energy expenditure, and body composition"],"prefix":"10.1093","volume":"2023","author":[{"given":"Sarah A","family":"Purcell","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, University of British Columbia , Vancouver, Canada"},{"name":"Irving K. Barber Faculty of Science, Department of Biology, University of British Columbia Okanagan , Kelowna, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieuwertje E","family":"Kok","sequence":"additional","affiliation":[{"name":"Division of Human Nutrition and Health, Wageningen University & Research , Wageningen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Ketterl","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology and Bone Marrow Transplant, Department of Pediatrics, University of Washington , Seattle, WA, USA"},{"name":"Cancer and Blood Disorders Center, Seattle Children\u2019s Hospital , Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam B","family":"Garcia","sequence":"additional","affiliation":[{"name":"Division of Pediatrics, The University of Texas MD Anderson Cancer Center , Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenat","family":"Joffe","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Cohen Children\u2019s Medical Center, Donald and Barbara Zucker School of Medicine at Hofstra, Northwell Health , New Hyde Park, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin C","family":"Brown","sequence":"additional","affiliation":[{"name":"Pennington Biomedical Research Center , Baton Rouge, LA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9093-7259","authenticated-orcid":false,"given":"Christina M","family":"Dieli-Conwright","sequence":"additional","affiliation":[{"name":"Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute , Boston, MA, USA"},{"name":"Harvard Medical School , Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant R","family":"Williams","sequence":"additional","affiliation":[{"name":"Institute for Cancer Outcomes and Survivorship, Division of Hematology\/Oncology, Department of Medicine, University of Alabama at Birmingham , Birmingham, AL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,5,4]]},"reference":[{"issue":"1","key":"2023050410421282600_lgad010-B1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"2023050410421282600_lgad010-B2","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1200\/JCO.2021.39.15_suppl.3095","article-title":"Does oxaliplatin pharmacokinetics (PKs) explain associations between body composition and chemotherapy toxicity risk in older adults with gastrointestinal (GI) cancers?","volume":"39(suppl 15)","author":"Williams","year":"2021","journal-title":"J Clin Oncol"},{"issue":"1","key":"2023050410421282600_lgad010-B3","first-page":"101363","article-title":"Chemotherapy dosing in older adults with cancer: One size does NOT fit all","volume":"14","author":"Williams","year":"2023"},{"issue":"7","key":"2023050410421282600_lgad010-B4","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/jcsm.12379","article-title":"The evolution of body composition in oncology-epidemiology, clinical trials, and the future of patient care: facts and numbers","volume":"9","author":"Brown","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2023050410421282600_lgad010-B5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejca.2015.12.030","article-title":"Prognostic value of sarcopenia in adults with solid tumours: a meta-analysis and systematic review","volume":"57","author":"Shachar","year":"2016","journal-title":"Eur J Cancer"},{"issue":"10","key":"2023050410421282600_lgad010-B6","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.1016\/j.clnu.2021.08.023","article-title":"Low skeletal muscle mass is a predictor of treatment related toxicity in oncologic patients. A meta-analysis","volume":"40","author":"Surov","year":"2021","journal-title":"Clin Nutr"},{"key":"2023050410421282600_lgad010-B7","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1093\/annonc\/mdx810","article-title":"Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy","volume":"29(suppl 2)","author":"Baracos","year":"2018","journal-title":"Ann Oncol"},{"key":"2023050410421282600_lgad010-B8","doi-asserted-by":"crossref","first-page":"102839","DOI":"10.1016\/j.critrevonc.2019.102839","article-title":"Myosteatosis and prognosis in cancer: systematic review and meta-analysis","volume":"145","author":"Aleixo","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"issue":"17","key":"2023050410421282600_lgad010-B9","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1007\/s40265-017-0832-z","article-title":"A review of food-drug interactions on oral drug absorption","volume":"77","author":"Deng","year":"2017","journal-title":"Drugs"},{"key":"2023050410421282600_lgad010-B10","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ejpb.2016.11.034","article-title":"Food, gastrointestinal pH, and models of oral drug absorption","volume":"112","author":"Abuhelwa","year":"2017","journal-title":"Eur J Pharm Biopharm"},{"issue":"15","key":"2023050410421282600_lgad010-B11","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.2165\/00003088-200443150-00005","article-title":"Effects of food on the clinical pharmacokinetics of anticancer agents: underlying mechanisms and implications for oral chemotherapy","volume":"43","author":"Singh","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"2023050410421282600_lgad010-B12","author":"Food and Drug Administration","year":"2002"},{"issue":"4","key":"2023050410421282600_lgad010-B13","doi-asserted-by":"crossref","first-page":"e255","DOI":"10.1200\/JOP.2013.001183","article-title":"Oral chemotherapy food and drug interactions: a comprehensive review of the literature","volume":"10","author":"Segal","year":"2014","journal-title":"J Oncol Pract"},{"key":"2023050410421282600_lgad010-B14","volume-title":"Guideline on the Investigation of Drug Interactions","author":"European Medicines Agency","year":"2012"},{"key":"2023050410421282600_lgad010-B15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejps.2019.04.003","article-title":"The mechanisms of pharmacokinetic food-drug interactions - a perspective from the UNGAP group","volume":"134","author":"Koziolek","year":"2019","journal-title":"Eur J Pharm Sci"},{"issue":"12","key":"2023050410421282600_lgad010-B16","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1200\/JCO.2015.65.2560","article-title":"Influence of the acidic beverage cola on the absorption of erlotinib in patients with non-small-cell lung cancer","volume":"34","author":"van Leeuwen","year":"2016","journal-title":"J Clin Oncol"},{"issue":"14","key":"2023050410421282600_lgad010-B17","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1200\/JCO.2017.76.4381","article-title":"Prospective international randomized phase II study of low-dose abiraterone with food versus standard dose abiraterone in castration-resistant prostate cancer","volume":"36","author":"Szmulewitz","year":"2018","journal-title":"J Clin Oncol"},{"issue":"2","key":"2023050410421282600_lgad010-B18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1208\/s12248-009-9099-y","article-title":"Population-based mechanistic prediction of oral drug absorption","volume":"11","author":"Jamei","year":"2009","journal-title":"AAPS J"},{"issue":"2","key":"2023050410421282600_lgad010-B19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1177\/1078155216679026","article-title":"Patient perspectives on the barriers associated with medication adherence to oral chemotherapy","volume":"24","author":"Muluneh","year":"2018","journal-title":"J Oncol Pharm Pract"},{"key":"2023050410421282600_lgad010-B20","doi-asserted-by":"publisher","first-page":"111838","DOI":"10.1016\/j.nut.2022.111838:111838","article-title":"Dietary choices following a cancer diagnosis: a narrative review","volume":"103-104","author":"Ford","year":"2022","journal-title":"Nutrition"},{"issue":"3","key":"2023050410421282600_lgad010-B21","doi-asserted-by":"crossref","first-page":"243","DOI":"10.5144\/0256-4947.2012.243","article-title":"Fasting among Muslim cancer patients during the holy month of Ramadan","volume":"32","author":"Zeeneldin","year":"2012","journal-title":"Ann Saudi Med"},{"issue":"8","key":"2023050410421282600_lgad010-B22","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/jjco\/hyu070","article-title":"The behavior of Turkish cancer patients in fasting during the holy month of Ramadan","volume":"44","author":"Tas","year":"2014","journal-title":"Jpn J Clin Oncol"},{"issue":"6","key":"2023050410421282600_lgad010-B23","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/jcpt.12578","article-title":"Effect of ketogenic diet and other dietary therapies on anti-epileptic drug concentrations in patients with epilepsy","volume":"42","author":"Heo","year":"2017","journal-title":"J Clin Pharm Ther"},{"issue":"11","key":"2023050410421282600_lgad010-B24","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1111\/epi.16364","article-title":"Pharmacokinetic interaction between modified Atkins diet and antiepileptic drugs in adults with drug-resistant epilepsy","volume":"60","author":"Kverneland","year":"2019","journal-title":"Epilepsia"},{"issue":"7","key":"2023050410421282600_lgad010-B25","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1080\/17425255.2016.1192126","article-title":"A short-term high fat diet increases exposure to midazolam and omeprazole in healthy subjects","volume":"12","author":"Achterbergh","year":"2016","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"4","key":"2023050410421282600_lgad010-B26","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/clpt.1987.48","article-title":"Increased clearance of propranolol and theophylline by high-protein compared with high-carbohydrate diet","volume":"41","author":"Fagan","year":"1987","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"2023050410421282600_lgad010-B27","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/01635581.2017.1299878","article-title":"Impact of undernutrition on the pharmacokinetics and pharmacodynamics of anticancer drugs: a literature review","volume":"69","author":"P\u00e9rez-Pitarch","year":"2017","journal-title":"Nutr Cancer"},{"issue":"1","key":"2023050410421282600_lgad010-B28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/014860719401800145","article-title":"Effect of protein-calorie malnutrition on methotrexate pharmacokinetics","volume":"18","author":"Charland","year":"1994","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"3","key":"2023050410421282600_lgad010-B29","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.2042-7158.2011.01413.x","article-title":"Effect of low-protein diet on anthracycline pharmacokinetics and cardiotoxicity","volume":"64","author":"El-Demerdash","year":"2012","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"2023050410421282600_lgad010-B30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12916-017-0873-x","article-title":"When less may be more: calorie restriction and response to cancer therapy","volume":"15","author":"O\u2019Flanagan","year":"2017","journal-title":"BMC Med"},{"key":"2023050410421282600_lgad010-B31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1146\/annurev-cancerbio-060820-090737","article-title":"Nutritional preconditioning in cancer treatment in relation to DNA damage and aging","volume":"5","author":"van den Boogaard","year":"2021","journal-title":"Annu Rev Cancer Biol"},{"issue":"4","key":"2023050410421282600_lgad010-B32","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1080\/01635581.2021.1938147","article-title":"Effects of fasting on chemotherapy treatment response: a systematic review of current evidence and suggestions for the design of future clinical trials","volume":"74","author":"Costa","year":"2022","journal-title":"Nutr Cancer"},{"issue":"5","key":"2023050410421282600_lgad010-B33","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/cpt.2094","article-title":"Effects of protein and calorie restriction on the metabolism and toxicity profile of irinotecan in cancer patients","volume":"109","author":"Man","year":"2021","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"2023050410421282600_lgad010-B34","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s13046-019-1189-9","article-title":"Effects of short-term fasting on cancer treatment","volume":"38","author":"de Groot","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"2023050410421282600_lgad010-B35","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1016\/S1470-2045(21)00639-2","article-title":"Toxicity and efficacy of chronomodulated chemotherapy: a systematic review","volume":"23","author":"Printezi","year":"2022","journal-title":"Lancet Oncol"},{"issue":"4","key":"2023050410421282600_lgad010-B36","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/SPC.0000000000000298","article-title":"Implications of weight loss for cancer patients receiving radiotherapy","volume":"11","author":"Lau","year":"2017","journal-title":"Curr Opin Support Palliat Care"},{"issue":"1","key":"2023050410421282600_lgad010-B37","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1200\/JCO.2014.56.1894","article-title":"Diagnostic criteria for the classification of cancer-associated weight loss","volume":"33","author":"Martin","year":"2015","journal-title":"J Clin Oncol"},{"issue":"1","key":"2023050410421282600_lgad010-B38","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/0899-9007(95)00067-4","article-title":"Definition of standardized nutritional assessment and interventional pathways in oncology","volume":"12","author":"Ottery","year":"1996","journal-title":"Nutrition"},{"issue":"23","key":"2023050410421282600_lgad010-B39","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1002\/cncr.33122","article-title":"Association of malnutrition with geriatric assessment impairments and health-related quality of life among older adults with gastrointestinal malignancies","volume":"126","author":"Williams","year":"2020","journal-title":"Cancer"},{"issue":"5","key":"2023050410421282600_lgad010-B40","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/MCO.0000000000000389","article-title":"Assessing nutritional status in cancer: role of the Patient-Generated Subjective Global Assessment","volume":"20","author":"Jager-Wittenaar","year":"2017","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"2","key":"2023050410421282600_lgad010-B41","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1634\/theoncologist.2019-0289","article-title":"Impact of baseline nutrition and exercise status on toxicity and outcomes in phase I and II oncology clinical trial participants","volume":"25","author":"Jain","year":"2020","journal-title":"Oncologist"},{"key":"2023050410421282600_lgad010-B42","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ejca.2016.05.011","article-title":"Chemotherapy dose intensity predicted by baseline nutrition assessment in gastrointestinal malignancies: a multicentre analysis","volume":"63","author":"Klute","year":"2016","journal-title":"Eur J Cancer"},{"issue":"2","key":"2023050410421282600_lgad010-B43","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ygyno.2011.07.093","article-title":"Evaluation of the Patient-Generated Subjective Global Assessment (PG-SGA) as a predictor of febrile neutropenia in gynecologic cancer patients receiving combination chemotherapy: a pilot study","volume":"123","author":"Phippen","year":"2011","journal-title":"Gynecol Oncol"},{"key":"2023050410421282600_lgad010-B44","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1200\/JCO.2021.39.15_suppl.3095","article-title":"Does oxaliplatin pharmacokinetics (PKs) explain associations between body composition and chemotherapy toxicity risk in older adults with gastrointestinal (GI) cancers?","volume":"39(suppl 15)","author":"Williams","year":"2021","journal-title":"J Clin Oncol"},{"issue":"1","key":"2023050410421282600_lgad010-B45","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.clnu.2018.12.038","article-title":"Determinants of change in resting energy expenditure in patients with stage III\/IV colorectal cancer","volume":"39","author":"Purcell","year":"2020","journal-title":"Clin Nutr"},{"issue":"2","key":"2023050410421282600_lgad010-B46","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/ajcn\/nqz112","article-title":"Total energy expenditure in patients with colorectal cancer: associations with body composition, physical activity, and energy recommendations","volume":"110","author":"Purcell","year":"2019","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"2023050410421282600_lgad010-B47","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.clnu.2022.02.016","article-title":"Energy expenditure profiles and the risk of early limiting toxicity in older patients with cancer: the ELCAPA-25 prospective cohort survey","volume":"41","author":"Boudou-Rouquette","year":"2022","journal-title":"Clin Nutr"},{"issue":"5","key":"2023050410421282600_lgad010-B48","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/ajcn\/65.5.1495","article-title":"Reduced rates of metabolism and decreased physical activity in breast cancer patients receiving adjuvant chemotherapy","volume":"65","author":"Demark-Wahnefried","year":"1997","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"2023050410421282600_lgad010-B49","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1042\/CS19990273","article-title":"Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement","volume":"98","author":"Barber","year":"2000","journal-title":"Clin Sci"},{"issue":"2","key":"2023050410421282600_lgad010-B50","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1042\/cs0770133","article-title":"Diet-induced thermogenesis in patients with gastrointestinal cancer cachexia","volume":"77","author":"Weston","year":"1989","journal-title":"Clin Sci (Lond))"},{"key":"2023050410421282600_lgad010-B51","doi-asserted-by":"crossref","first-page":"573275","DOI":"10.3389\/fendo.2020.573275","article-title":"Factors influencing insulin absorption around exercise in type 1 diabetes","volume":"11","author":"Pitt","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"2023050410421282600_lgad010-B52","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1007\/s00125-016-3981-9","article-title":"Insulin pump basal adjustment for exercise in type 1 diabetes: a randomised crossover study","volume":"59","author":"McAuley","year":"2016","journal-title":"Diabetologia"},{"issue":"4","key":"2023050410421282600_lgad010-B53","doi-asserted-by":"crossref","DOI":"10.19080\/AJPN.2019.07.555775","article-title":"The potential role of exercise on the bioavailability of cancer treatments","volume":"7","author":"Curnier","year":"2019","journal-title":"Acad J Pediatr Neonatol"},{"issue":"14","key":"2023050410421282600_lgad010-B54","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1158\/0008-5472.CAN-16-0887","article-title":"Efficacy and mechanisms of aerobic exercise on cancer initiation, progression, and metastasis: a critical systematic review of in vivo preclinical data","volume":"76","author":"Ashcraft","year":"2016","journal-title":"Cancer Res"},{"key":"2023050410421282600_lgad010-B55","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fonc.2019.00035","article-title":"Impact of physical exercise on growth and progression of cancer in rodents-a systematic review and meta-analysis","volume":"9","author":"Eschke","year":"2019","journal-title":"Front Oncol"},{"issue":"19","key":"2023050410421282600_lgad010-B56","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1158\/0008-5472.CAN-21-1258","article-title":"Effects of exercise on cancer treatment efficacy: a systematic review of preclinical and clinical studies","volume":"81","author":"Yang","year":"2021","journal-title":"Cancer Res"},{"issue":"1","key":"2023050410421282600_lgad010-B57","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.semradonc.2018.10.001","article-title":"Exercise as adjunct therapy in cancer","volume":"29","author":"Ashcraft","year":"2019","journal-title":"Semin Radiat Oncol"},{"key":"2023050410421282600_lgad010-B58","doi-asserted-by":"crossref","first-page":"575657","DOI":"10.3389\/fonc.2020.575657","article-title":"Translating preclinical research for exercise oncology: take it to the VO(2max)","volume":"10","author":"Lamkin","year":"2020","journal-title":"Front Oncol"},{"issue":"9","key":"2023050410421282600_lgad010-B59","doi-asserted-by":"crossref","first-page":"e27835","DOI":"10.1002\/pbc.27835","article-title":"Vascular modulation through exercise improves chemotherapy efficacy in Ewing sarcoma","volume":"66","author":"Morrell","year":"2019","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"2023050410421282600_lgad010-B60","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00520-019-04871-5","article-title":"Aerobic exercise during chemotherapy infusion for cancer treatment: a novel randomised crossover safety and feasibility trial","volume":"28","author":"Thomas","year":"2020","journal-title":"Support Care Cancer"},{"key":"2023050410421282600_lgad010-B61","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.critrevonc.2019.02.005","article-title":"Impact of exercise on chemotherapy completion rate: a systematic review of the evidence and recommendations for future exercise oncology research","volume":"136","author":"Bland","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"issue":"22","key":"2023050410421282600_lgad010-B62","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1200\/JCO.22.00687","article-title":"Exercise, diet, and weight management during cancer treatment: ASCO guideline","volume":"40","author":"Ligibel","year":"2022","journal-title":"J Clin Oncol"},{"issue":"10112","key":"2023050410421282600_lgad010-B63","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1016\/S0140-6736(17)31610-0","article-title":"The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE)","volume":"390","author":"Bhakta","year":"2017","journal-title":"Lancet"},{"issue":"11","key":"2023050410421282600_lgad010-B64","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9113780","article-title":"The predictive value of low skeletal muscle mass assessed on cross-sectional imaging for anti-cancer drug toxicity: a systematic review and meta-analysis","volume":"9","author":"Huiskamp","year":"2020","journal-title":"J Clin Med"},{"issue":"8","key":"2023050410421282600_lgad010-B65","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/gerona\/glw017","article-title":"Sarcopenia is associated with lower skeletal muscle capillarization and exercise capacity in older adults","volume":"71","author":"Prior","year":"2016","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"2023050410421282600_lgad010-B66","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jgo.2017.08.002","article-title":"Frailty and skeletal muscle in older adults with cancer","volume":"9","author":"Williams","year":"2018","journal-title":"J Geriatr Oncol"},{"issue":"20","key":"2023050410421282600_lgad010-B67","doi-asserted-by":"crossref","first-page":"33658","DOI":"10.18632\/oncotarget.16866","article-title":"Skeletal muscle measures and physical function in older adults with cancer: sarcopenia or myopenia?","volume":"8","author":"Williams","year":"2017","journal-title":"Oncotarget"},{"issue":"7","key":"2023050410421282600_lgad010-B68","first-page":"853","article-title":"The use of body surface area as a criterion of drug dosage in cancer chemotherapy","volume":"18","author":"Pinkel","year":"1958","journal-title":"Cancer Res"},{"issue":"24","key":"2023050410421282600_lgad010-B69","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1093\/jnci\/94.24.1883","article-title":"Role of body surface area in dosing of investigational anticancer agents in adults, 1991-2001","volume":"94","author":"Baker","year":"2002","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"2023050410421282600_lgad010-B70","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1200\/JCO.1996.14.9.2590","article-title":"Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative","volume":"14","author":"Gurney","year":"1996","journal-title":"J Clin Oncol"},{"issue":"8","key":"2023050410421282600_lgad010-B71","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.2174\/18715206113139990322","article-title":"Assessment of nutritional status in cancer\u2013the relationship between body composition and pharmacokinetics","volume":"13","author":"Prado","year":"2013","journal-title":"Anticancer Agents Med Chem"},{"issue":"9","key":"2023050410421282600_lgad010-B72","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1080\/17512433.2017.1347503","article-title":"A review of body composition and pharmacokinetics in oncology","volume":"10","author":"Hopkins","year":"2017","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"1","key":"2023050410421282600_lgad010-B73","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00280-010-1288-y","article-title":"An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity","volume":"67","author":"Prado","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"issue":"5","key":"2023050410421282600_lgad010-B74","doi-asserted-by":"crossref","first-page":"e37563","DOI":"10.1371\/journal.pone.0037563","article-title":"Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma","volume":"7","author":"Mir","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"2023050410421282600_lgad010-B75","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00280-017-3487-2","article-title":"The impact of skeletal muscle on the pharmacokinetics and toxicity of 5-fluorouracil in colorectal cancer","volume":"81","author":"Williams","year":"2018","journal-title":"Cancer Chemother Pharmacol"},{"issue":"3","key":"2023050410421282600_lgad010-B76","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1002\/cam4.5118","article-title":"Influence of the skeletal muscle index on pharmacokinetics and toxicity of fluorouracil","volume":"12","author":"Schmulenson","year":"2023","journal-title":"Cancer Med"},{"issue":"14","key":"2023050410421282600_lgad010-B77","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1002\/cam4.4038","article-title":"Worse capecitabine treatment outcome in patients with a low skeletal muscle mass is not explained by altered pharmacokinetics","volume":"10","author":"Molenaar-Kuijsten","year":"2021","journal-title":"Cancer Med"},{"key":"2023050410421282600_lgad010-B78","doi-asserted-by":"crossref","first-page":"101733","DOI":"10.1016\/j.canep.2020.101733","article-title":"Childhood cancer: survival, treatment modalities, late effects and improvements over time","volume":"71(pt B)","author":"Erdmann","year":"2021","journal-title":"Cancer Epidemiol"},{"issue":"1","key":"2023050410421282600_lgad010-B79","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/cam4.3584","article-title":"Skeletal muscle and adipose tissue changes in the first phase of treatment of pediatric solid tumors","volume":"10","author":"Joffe","year":"2021","journal-title":"Cancer Med"},{"issue":"6","key":"2023050410421282600_lgad010-B80","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S2352-4642(19)30407-9","article-title":"Nutrition during childhood cancer treatment: current understanding and a path for future research","volume":"4","author":"Joffe","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"issue":"9","key":"2023050410421282600_lgad010-B81","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.bbmt.2011.01.013","article-title":"Busulfan dosing in children with BMIs \u2265 85% undergoing HSCT: a new optimal strategy","volume":"17","author":"Browning","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"2023050410421282600_lgad010-B82","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00007691-199101000-00004","article-title":"Fat body mass and pharmacokinetics of oral 6-mercaptopurine in children with acute lymphoblastic leukemia","volume":"13","author":"Zuccaro","year":"1991","journal-title":"Ther Drug Monit"},{"issue":"2","key":"2023050410421282600_lgad010-B83","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00280-008-0854-z","article-title":"Impact of body composition on pharmacokinetics of doxorubicin in children: a Glaser Pediatric Research Network study","volume":"64","author":"Thompson","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"issue":"6","key":"2023050410421282600_lgad010-B84","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/jcph.1799","article-title":"Effect of body fat on population pharmacokinetics of high-dose methotrexate in pediatric patients with acute lymphoblastic leukemia","volume":"61","author":"Orgel","year":"2021","journal-title":"J Clin Pharmacol"},{"issue":"5","key":"2023050410421282600_lgad010-B85","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.phrs.2010.01.007","article-title":"Diet-induced obesity alters vincristine pharmacokinetics in blood and tissues of mice","volume":"61","author":"Behan","year":"2010","journal-title":"Pharmacol Res"},{"issue":"3","key":"2023050410421282600_lgad010-B86","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/08880018.2020.1842952","article-title":"Association of body mass index with toxicity and survival in pediatric patients treated with cisplatin-containing regimens","volume":"38","author":"Bhandari","year":"2021","journal-title":"Pediatr Hematol Oncol"},{"issue":"6","key":"2023050410421282600_lgad010-B87","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00280-021-04357-4","article-title":"Population pharmacokinetic analysis of crizotinib in children with progressive\/recurrent high-grade and diffuse intrinsic pontine gliomas","volume":"88","author":"Gibson","year":"2021","journal-title":"Cancer Chemother Pharmacol"},{"issue":"10","key":"2023050410421282600_lgad010-B88","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1158\/1078-0432.CCR-13-2364","article-title":"Population pharmacokinetics of bevacizumab in children with osteosarcoma: implications for dosing","volume":"20","author":"Turner","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"17","key":"2023050410421282600_lgad010-B89","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1200\/JCO.2008.20.8983","article-title":"Future of cancer incidence in the United States: burdens upon an aging, changing nation","volume":"27","author":"Smith","year":"2009","journal-title":"J Clin Oncol"},{"issue":"4","key":"2023050410421282600_lgad010-B90","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jgo.2015.12.002","article-title":"Comorbidity in older adults with cancer","volume":"7","author":"Williams","year":"2016","journal-title":"J Geriatr Oncol"},{"issue":"4","key":"2023050410421282600_lgad010-B91","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1634\/theoncologist.2014-0247","article-title":"Geriatric assessment-identified deficits in older cancer patients with normal performance status","volume":"20","author":"Jolly","year":"2015","journal-title":"Oncologist"},{"issue":"2","key":"2023050410421282600_lgad010-B92","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.clnu.2009.09.003","article-title":"Older adults and patients in need of nutritional support: review of current treatment options and factors influencing nutritional intake","volume":"29","author":"Nieuwenhuizen","year":"2010","journal-title":"Clin Nutr"},{"key":"2023050410421282600_lgad010-B93","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.maturitas.2019.05.006","article-title":"Prevalence of protein-energy malnutrition risk in European older adults in community, residential and hospital settings, according to 22 malnutrition screening tools validated for use in adults \u226565 years: a systematic review and meta-analysis","volume":"126","author":"Leij-Halfwerk","year":"2019","journal-title":"Maturitas"},{"issue":"4","key":"2023050410421282600_lgad010-B94","doi-asserted-by":"crossref","first-page":"826","DOI":"10.3945\/ajcn.2009.28540","article-title":"Associations between energy demands, physical activity, and body composition in adult humans between 18 and 96 y of age","volume":"92","author":"Speakman","year":"2010","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"2023050410421282600_lgad010-B95","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jgo.2018.10.009","article-title":"Sarcopenia & aging in cancer","volume":"10","author":"Williams","year":"2019","journal-title":"J Geriatr Oncol"},{"issue":"19","key":"2023050410421282600_lgad010-B96","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1200\/JCO.21.00102","article-title":"Sarcopenia in the older adult with cancer","volume":"39","author":"Williams","year":"2021","journal-title":"J Clin Oncol"},{"issue":"7","key":"2023050410421282600_lgad010-B97","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1158\/1055-9965.EPI-17-0200","article-title":"Explaining the obesity paradox: the association between body composition and colorectal cancer survival (C-SCANS Study)","volume":"26","author":"Caan","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"2023050410421282600_lgad010-B98","doi-asserted-by":"crossref","first-page":"e204783","DOI":"10.1001\/jamanetworkopen.2020.4783","article-title":"Assessment of sarcopenia measures, survival, and disability in older adults before and after diagnosis with cancer","volume":"3","author":"Williams","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"36","key":"2023050410421282600_lgad010-B99","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1200\/JCO.19.02588","article-title":"Bridging the data-free zone: decision making for older adults with cancer","volume":"37","author":"Rocque","year":"2019","journal-title":"J Clin Oncol"},{"issue":"12","key":"2023050410421282600_lgad010-B100","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1200\/JCO.2005.03.9289","article-title":"Prospective evaluation of the relationship of patient age and paclitaxel clinical pharmacology: Cancer and Leukemia Group B (CALGB 9762)","volume":"24","author":"Lichtman","year":"2006","journal-title":"J Clin Oncol"}],"container-title":["JNCI Monographs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jncimono\/article-pdf\/2023\/61\/3\/50189066\/lgad010.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jncimono\/article-pdf\/2023\/61\/3\/50189066\/lgad010.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T10:58:40Z","timestamp":1683197920000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jncimono\/article\/2023\/61\/3\/7150911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,4]]},"references-count":100,"journal-issue":{"issue":"61","published-online":{"date-parts":[[2023,5,4]]},"published-print":{"date-parts":[[2023,5,4]]}},"URL":"https:\/\/doi.org\/10.1093\/jncimonographs\/lgad010","relation":{},"ISSN":["1052-6773","1745-6614"],"issn-type":[{"value":"1052-6773","type":"print"},{"value":"1745-6614","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,6,1]]},"published":{"date-parts":[[2023,5,4]]}}}